Implementation of daily patient-reported outcome measurements to support children with cancer.
Andreas MerykGabriele KropshoferBenjamin HetzerDavid RiedlJens LehmannGerhard RumpoldAlexandra HaidBernhard HolznerRoman CrazzolaraPublished in: Pediatric blood & cancer (2021)
Our study shows that daily symptom monitoring is feasible for all children with newly diagnosed cancer aged 5-18 years. Monitoring offers the opportunity to identify symptoms early and trigger appropriate clinical action.